Skip to main content
Erschienen in: International Urogynecology Journal 7/2007

01.07.2007 | Original Article

Anterior vaginal wall prolapse and voiding dysfunction in urogynecology patients

verfasst von: Megan O. Schimpf, David M. O’Sullivan, Christine A. LaSala, Paul K. Tulikangas

Erschienen in: International Urogynecology Journal | Ausgabe 7/2007

Einloggen, um Zugang zu erhalten

Abstract

We investigated whether women with and without anterior vaginal wall prolapse have voiding differences. Women (n = 109) who presented to a urogynecology practice were categorized into two groups based on anterior vaginal wall prolapse: stages 0 and 1 and stages 2, 3, and 4. Women with prolapse were older than the women without prolapse but the groups were otherwise similar demographically. There was a higher rate of activity-related urine loss and use of wetness protection amongst women without prolapse. There was no significant difference for urgency symptoms or urge incontinence. Urodynamic testing found no significant differences for maximal flow rate or maximal urethral closing pressures. Postvoid residual volume and detrusor overactivity were not different but approached significance. Anterior vaginal wall prolapse of stage 2 or greater was not associated with urge incontinence or voiding function in this population. Women without prolapse were more likely to report stress incontinence.
Literatur
1.
Zurück zum Zitat Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89(4):501–506PubMedCrossRef Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89(4):501–506PubMedCrossRef
2.
Zurück zum Zitat Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A (2002) Pelvic organ prolapse in the Women’s Health Initiative: gravity and gravidity. Am J Obstet Gynecol 186(6):1160–1166PubMedCrossRef Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A (2002) Pelvic organ prolapse in the Women’s Health Initiative: gravity and gravidity. Am J Obstet Gynecol 186(6):1160–1166PubMedCrossRef
3.
Zurück zum Zitat Rosenzweig BA, Pushkin S, Blumenfield D, Bhatia NN (1992) Prevalence of abnormal urodynamic test results in continent women with severe genitourinary prolapse. Obstet Gynecol 79(4):539–542PubMed Rosenzweig BA, Pushkin S, Blumenfield D, Bhatia NN (1992) Prevalence of abnormal urodynamic test results in continent women with severe genitourinary prolapse. Obstet Gynecol 79(4):539–542PubMed
4.
Zurück zum Zitat Bai SW, Kang SH, Kim SK, Kim JY, Park KH (2003) The effect of pelvic organ prolapse on lower urinary tract function. Yonsei Med J 44(1):94–98PubMed Bai SW, Kang SH, Kim SK, Kim JY, Park KH (2003) The effect of pelvic organ prolapse on lower urinary tract function. Yonsei Med J 44(1):94–98PubMed
5.
Zurück zum Zitat Groutz A, Gordon D, Lessing JB, Wolman I, Jaffa A, David MP (1999) Prevalence and characteristics and voiding difficulties in women: are subjective symptoms substantiated by objective urodynamic data? Urology 54(2):268–272PubMedCrossRef Groutz A, Gordon D, Lessing JB, Wolman I, Jaffa A, David MP (1999) Prevalence and characteristics and voiding difficulties in women: are subjective symptoms substantiated by objective urodynamic data? Urology 54(2):268–272PubMedCrossRef
6.
Zurück zum Zitat Costantini E, Mearini E, Pajoncini C, Biscotta S, Bini V, Porena M (2003) Uroflowmetry in female voiding disturbances. Neurourol Urodyn 22(6):569–573PubMedCrossRef Costantini E, Mearini E, Pajoncini C, Biscotta S, Bini V, Porena M (2003) Uroflowmetry in female voiding disturbances. Neurourol Urodyn 22(6):569–573PubMedCrossRef
7.
Zurück zum Zitat Berni KC, Cummings JM (2004) Urodynamic evaluation of the older adult: bench to bedside. Clin Geriatr Med 20(3):477–487PubMedCrossRef Berni KC, Cummings JM (2004) Urodynamic evaluation of the older adult: bench to bedside. Clin Geriatr Med 20(3):477–487PubMedCrossRef
8.
Zurück zum Zitat Coates KW, Harris RL, Cundiff GW, Bump RC (1997) Uroflowmetry in women with urinary incontinence and pelvic organ prolapse. Br J Urol 80(2):217–221PubMed Coates KW, Harris RL, Cundiff GW, Bump RC (1997) Uroflowmetry in women with urinary incontinence and pelvic organ prolapse. Br J Urol 80(2):217–221PubMed
9.
Zurück zum Zitat Rosenzweig BA, Soffici AR, Thomas S, Bhatia NN (1992) Urodynamic evaluation of voiding in women with cystocele. J Reprod Med 37(2):162–166PubMed Rosenzweig BA, Soffici AR, Thomas S, Bhatia NN (1992) Urodynamic evaluation of voiding in women with cystocele. J Reprod Med 37(2):162–166PubMed
10.
Zurück zum Zitat Haylen BT, Law MG, Frazer M, Schulz S (1999) Urine flow rates and residual urine volumes in urogynecology patients. Int Urogynecol J Pelvic Floor Dysfunct 10(6):378–383PubMedCrossRef Haylen BT, Law MG, Frazer M, Schulz S (1999) Urine flow rates and residual urine volumes in urogynecology patients. Int Urogynecol J Pelvic Floor Dysfunct 10(6):378–383PubMedCrossRef
11.
Zurück zum Zitat Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JO, Klarskov P et al (1996) The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 175(1):10–17PubMedCrossRef Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JO, Klarskov P et al (1996) The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 175(1):10–17PubMedCrossRef
12.
Zurück zum Zitat Swift S, Woodman P, O’Boyle A, Kahn M, Valley M, Bland D, Wang W, Schaffer J (2005) Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol 192(3):795–806PubMedCrossRef Swift S, Woodman P, O’Boyle A, Kahn M, Valley M, Bland D, Wang W, Schaffer J (2005) Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol 192(3):795–806PubMedCrossRef
13.
Zurück zum Zitat Romanzi LJ, Chaikin DC, Blaivas JG (1999) The effect of genital prolapse on voiding. J Urol 161(2):581–586PubMedCrossRef Romanzi LJ, Chaikin DC, Blaivas JG (1999) The effect of genital prolapse on voiding. J Urol 161(2):581–586PubMedCrossRef
14.
Zurück zum Zitat Stern JA, Hseih YC, Schaeffer AJ (2004) Residual urine in an elderly female population: novel implications for oral estrogen replacement and impact on recurrent urinary tract infection. J Urol 171:768–770PubMedCrossRef Stern JA, Hseih YC, Schaeffer AJ (2004) Residual urine in an elderly female population: novel implications for oral estrogen replacement and impact on recurrent urinary tract infection. J Urol 171:768–770PubMedCrossRef
15.
Zurück zum Zitat Dietz HP, Haylen BT, Vancaillie TG (2002) Female pelvic organ prolapse and voiding function. Int Urogynecol J Pelvic Floor Dysfunct 13(5):284–288PubMedCrossRef Dietz HP, Haylen BT, Vancaillie TG (2002) Female pelvic organ prolapse and voiding function. Int Urogynecol J Pelvic Floor Dysfunct 13(5):284–288PubMedCrossRef
Metadaten
Titel
Anterior vaginal wall prolapse and voiding dysfunction in urogynecology patients
verfasst von
Megan O. Schimpf
David M. O’Sullivan
Christine A. LaSala
Paul K. Tulikangas
Publikationsdatum
01.07.2007
Verlag
Springer-Verlag
Erschienen in
International Urogynecology Journal / Ausgabe 7/2007
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-006-0227-2

Weitere Artikel der Ausgabe 7/2007

International Urogynecology Journal 7/2007 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.